- •
There is no need to withdraw cardioprotective aspirin for polypectomy.
- •
Avoid withdrawing either aspirin or thienopyridines within 30 days of cardiac stenting and consider postponing elective colonoscopy up to 12 months if feasible after placement of drug-eluting stents.
- •
If feasible, consider postponing elective colonoscopy until short-term anticoagulant treatment is completed.
- •
Do not withdraw antiplatelets or anticoagulants for low-risk bleeding procedures (ie, diagnostic colonoscopy with no
Colonoscopy, Polypectomy, and the Risk of Bleeding
Section snippets
Key points
Risks of colonoscopy
Although colonoscopy is generally considered a safe procedure, it is not without risks. Risks of colonoscopy include perforation, hemorrhage, complications of sedation, postpolypectomy coagulation syndrome, and (rarely) splenic rupture (Table 1). Indeed, colonoscopic complications (particularly perforation or hemorrhage) occur most commonly in patients who undergo polypectomy.2 Hemorrhage after removal of a polyp, termed postpolypectomy bleeding (PPB), can occur in 1 of 2 forms: immediate PPB
Risk factors for postpolypectomy bleeding
Polyp factors, patient factors, and even physician factors have been associated with an increased risk of immediate and/or delayed PPB.7, 8, 9, 10 Polyp-related factors include polyp size, polyp morphology, and polyp location in the colon. One of the major polyp-related risk factors for PPB is polyp size. In a study investigating pedunculated polyps, the PPB rate (immediate or delayed) for 98 polyps that were 1 to 1.9 cm was 3.1%, whereas PPB occurred in 15.1% of 66 polyps 2 cm or greater.11 In
Outcomes of patients with postpolypectomy bleeding
Fortunately, for patients who do experience PPB, this complication is not typically associated with any major long-term sequelae. In a study of 1657 subjects undergoing polypectomy, there were 5 with delayed PPB, all of whom received blood transfusion. Four of the 5 were treated successfully endoscopically, and PPB was controlled in the fifth with angiography after endoscopic treatment had failed. None of these subjects required surgery and none died of PPB.20 In the author’s study,
Considerations when referring patients for colonoscopy
When referring patients for colonoscopy, it is very important to carefully evaluate their regimen of antiplatelets or anticoagulants and the timing of the colonoscopy. The use of antiplatelets and anticoagulants is increasing given the high rates of coronary artery disease and cerebrovascular disease in the United States. The American Heart Association estimates that 83.6 million American adults have some form of cardiovascular disease, including approximately 15.4 million with coronary artery
Managing aspirin in the periprocedural period
Aspirin irreversibly acetylates and inactivates the platelet cyclooxygenase, thereby inactivating platelets for the duration of their lifespan, 7 to 10 days. Nevertheless, based on several retrospective studies,13, 20, 22 guidelines agree that aspirin can be safely continued during colonoscopy with polypectomy without concern for a significant increase in bleeding.23, 24, 25 Moreover, the cardiovascular risks associated with withdrawing aspirin can be high, especially in patients with a history
Managing thienopyridines in the periprocedural period
The thienopyridines inhibit platelet function by blocking adenosine diphosphate, which interferes with the platelets’ ability to aggregate. In patients with coronary artery disease, especially in the setting of coronary stents, thienopyridines are most frequently given in combination with aspirin, which is termed dual antiplatelet therapy (DAPT). For patients on continued thienopyridines during polypectomy, prospective data found the rate of PPB to be 2.4% and interestingly, all patients with
Managing warfarin in the periprocedural period
Warfarin is a commonly used anticoagulant agent that works by inhibiting vitamin K–dependent coagulation factor synthesis. This drug is used for treatment of a variety of disorders, including deep vein thrombosis (DVT); pulmonary embolism; ischemic stroke; and prophylaxis of arterial thromboembolism from atrial fibrillation, flutter, and cardiac valvular disorders. It is important to remember that, although the goal with interrupting anticoagulants periprocedurally is to reduce the risk of
Managing direct-acting oral anticoagulants in the periprocedural period
The direct-acting oral anticoagulants (DOACs) include the direct thrombin inhibitor, dabigatran; and the factor Xa inhibitors, rivaroxaban, apixaban, edoxaban, and betrixaban. Additionally, there are subcutaneous and intravenous direct thrombin inhibitors and factor Xa inhibitors (Table 2); however, this article focuses on the oral agents because they are the drugs most likely to be encountered in the setting of elective colonoscopy. The major advantages of the DOACs compared with warfarin are
When to readminister drugs after the procedure
After making the decision to discontinue an antiplatelet or anticoagulant in preparation for an endoscopic procedure, the next important decision is when to readminister the drug after the procedure. Unfortunately, the guidelines provide no clear consensus because there are very few studies on which to base the recommendations. For thienopyridines, the ACC/ACG (the joint guidelines from the American College of Cardiology and American College of Gastroenterology) recommend readministering “as
Summary
Colonoscopy with polypectomy is the means by which the incidence of colon cancer may be reduced; however, polypectomy is not without risk. Physicians must carefully weigh the risks and benefits of colonoscopy, particularly when patients are prescribed antiplatelet agents and anticoagulants. Aspirin and NSAIDs can be continued safely during colonoscopy with polypectomy. The risk of delayed PPB is increased if thienopyridines are continued and is increased even if warfarin therapy is interrupted.
References (45)
- et al.
Complications of colonoscopy
Gastrointest Endosc
(2011) - et al.
Hemoclipping for postpolypectomy and postbiopsy colonic bleeding
Gastrointest Endosc
(2000) - et al.
Colonoscopic polypectomy
Gastroenterol Clin North Am
(2008) - et al.
Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy
Clin Gastroenterol Hepatol
(2013) - et al.
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy
J Thromb Haemost
(2009) - et al.
Prophylactic clip application does not decrease delayed bleeding after colonoscopic polypectomy
Gastrointest Endosc
(2003) - et al.
Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions
Gastrointest Endosc
(2013) - et al.
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases
Gastrointest Endosc
(2004) - et al.
Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS
Gastrointest Endosc
(1994) - et al.
Management of antithrombotic agents for endoscopic procedures
Gastrointest Endosc
(2009)
Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis
J Am Coll Cardiol
Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines
Chest
The management of antithrombotic agents for patients undergoing GI endoscopy
Gastrointest Endosc
Dabigatran-induced esophagitis
Clin Gastroenterol Hepatol
Colorectal cancer facts & figures 2017-2019
Postpolypectomy colonic hemorrhage
Dis Colon Rectum
Colonoscopy: a prospective report of complications
J Clin Gastroenterol
Risk factors for severe delayed postpolypectomy bleeding
Endoscopy
Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study
Am J Gastroenterol
Detachable snare versus epinephrine injection in the prevention of postpolypectomy bleeding: a randomized and controlled study
Endoscopy
Meta-analysis: colonoscopic post-polypectomy bleeding in patients on continued clopidogrel therapy
Aliment Pharmacol Ther
Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin
Am J Gastroenterol
Cited by (8)
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline
2022, ChestCitation Excerpt :The following qualifying remarks apply to this empiric risk classification: Selected minimal-bleed-risk procedures may require 1 to 2 days of anticoagulant interruption if there is concern about bleeding: for example, a dental extraction may be more complex in a patient with poor dentition or compromised gingival integrity53; a screening colonoscopy in patients with a history of polyps that may require resection54; and coronary angiography with a femoral (instead of radial) artery access.48 Surgical procedures (eg, an inguinal hernia repair55) may vary widely in complexity and might be justifiably categorized as low-to-moderate- or high-bleed-risk.
Managing bleeding risk after cold snare polypectomy in patients receiving direct-acting oral anticoagulants
2022, Gastrointestinal EndoscopyCitation Excerpt :However, the proportion of patients receiving each type of DOACs in immediate bleeding was not significantly different in either group (Table 4). Although immediate postpolypectomy bleeding was more frequent than the previously assumed 1% to 2% associated with conventional polypectomy of a lesion >1 cm in a patient not on antithrombotic agents,15 differences may relate to definitions of immediate bleeding. In this study immediate bleeding was defined as spurting or oozing that continued for more than 60 seconds.
Antiplatelets, anticoagulants, and colonoscopic polypectomy
2020, Gastrointestinal EndoscopyCitation Excerpt :Removing lesions ≥1 cm is associated with a 1% to 2% PPB rate related to inadequate cauterization of underlying small vessels (immediate bleeding)8 or thermal injuries causing ulceration and delayed bleeding.2 Choice of electrocautery (pure-cut rather than blend-current), patient age (>65 years), polyp morphology, and antithrombotic agents also increase PPB.8,12 Nonthermal polypectomy of small lesions (≤1 cm) is believed to be associated with a lesser risk (<1%) given the absence of thermal injury related to cautery.
Establishment of a model for predicting delayed post-polypectomy bleeding: A real-world retrospective study
2022, Frontiers in MedicineTiming of Resumption of Anticoagulation After Polypectomy and Frequency of Post-procedural Complications: A Post-hoc Analysis
2022, Digestive Diseases and SciencesLower Gastrointestinal Bleeding: Current State of Diagnosis and Treatment and Interpretation of the Clinical Guidelines
2022, Journal of Sichuan University (Medical Science Edition)
Dr. Feagins current research is funded by a VA CSR&D MERIT Award grant number 5I01CX00815.